Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ Recombinant Human SorLA (aa 82-753) Protein, CF

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Manufacturer:  R&D Systems™ 9880LA050

Catalog No. 98-80LA-050


Add to cart
This item is not returnable. View return policy

Description

Description

The Recombinant Human SorLA (aa 82-753) Protein is derived from HEK293. The Recombinant Human SorLA (aa 82-753) Protein has been validated for the following applications: Bioactivity.
Specifications

Specifications

Q92673
Lyophilized from a 0.2 μm filtered solution in PBS.
76 kDa
50 μg
12 months from date of receipt, ≤ -20°C as supplied; 1 month, 2 to 8°C under sterile conditions after reconstitution; 3 months, ≤ -20°C under sterile conditions after reconstitution.
<0.10 EU per 1 μg of the protein by the LAL method.
SorLA
Reconstitute at 1 mg/mL in PBS.
Bioactivity
6653
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
Human embryonic kidney cell, HEK293-derived human SorLA protein Ser82-Pro753, with a C-terminal 6-His tag
RUO
Unconjugated
Human
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit